Fibroblast growth factor 2 and cyclic AMP synergistically regulate bone sialoprotein gene expression

Emi Shimizu, Youhei Nakayama, Yu Nakajima, Naoko Kato, Hideki Takai, Dong Soon Kim, Masato Arai, Ryoichiro Saito, Jaro Sodek, Yorimasa Ogata

Research output: Contribution to journalArticle

Abstract

Bone sialoprotein (BSP) is a noncollagenous protein of the mineralized bone extracellular matrix. We here report that FGF2 and cAMP act synergistically to stimulate BSP gene expression. Treatment of ROS 17/2.8 cells with either 10 ng/ml FGF2 or 1 μM FSK for 6 h resulted in 5.4- and 8.2-fold increases, respectively, in the levels of BSP mRNA. However, in the presence of both FGF2 and forskolin (FGF/FSK), BSP mRNA levels were increased synergistically by 20.4-fold. Using a luciferase reporter construct, encompassing BSP promoter nucleotides -116 to +60, transcription was also increased synergistically by 15.0-fold with FGF/FSK, compared to stimulations of 2.6- and 5.3-fold, respectively, for FGF2 and FSK alone. Transcriptional stimulation by FGF/FSK abrogated in constructs included 2 bp mutations in the inverted CCAAT, CRE, FRE and Pit-1 elements. Whereas the FRE-protein complex was increased by FGF2 and FGF/FSK, the Pit-1-protein complex was decreased by FSK and FGF/FSK. Notably, transcriptional activity induced by FGF/FSK was blocked by protein kinase A, tyrosine kinase and MEK inhibitors. These studies indicate that the combinatorial effects of FGF and FSK act through PKA, tyrosine kinase and MAP-kinase-dependent pathways, which target the inverted CCAAT, CRE, FRE and Pit-1 elements in the BSP gene to synergistically increase BSP expression.

Original languageEnglish (US)
Pages (from-to)42-52
Number of pages11
JournalBone
Volume39
Issue number1
DOIs
StatePublished - Jul 2006

Fingerprint

Integrin-Binding Sialoprotein
Fibroblast Growth Factor 2
Cyclic AMP
Gene Expression
Colforsin
Protein-Tyrosine Kinases
Mitogen-Activated Protein Kinase Kinases
Messenger RNA
Bone Matrix
Proteins
Cyclic AMP-Dependent Protein Kinases
Luciferases
Extracellular Matrix
Nucleotides

Keywords

  • Basic fibroblast growth factor
  • Bone sialoprotein
  • cAMP
  • Gene expression

ASJC Scopus subject areas

  • Physiology
  • Hematology

Cite this

Shimizu, E., Nakayama, Y., Nakajima, Y., Kato, N., Takai, H., Kim, D. S., ... Ogata, Y. (2006). Fibroblast growth factor 2 and cyclic AMP synergistically regulate bone sialoprotein gene expression. Bone, 39(1), 42-52. https://doi.org/10.1016/j.bone.2005.12.011

Fibroblast growth factor 2 and cyclic AMP synergistically regulate bone sialoprotein gene expression. / Shimizu, Emi; Nakayama, Youhei; Nakajima, Yu; Kato, Naoko; Takai, Hideki; Kim, Dong Soon; Arai, Masato; Saito, Ryoichiro; Sodek, Jaro; Ogata, Yorimasa.

In: Bone, Vol. 39, No. 1, 07.2006, p. 42-52.

Research output: Contribution to journalArticle

Shimizu, E, Nakayama, Y, Nakajima, Y, Kato, N, Takai, H, Kim, DS, Arai, M, Saito, R, Sodek, J & Ogata, Y 2006, 'Fibroblast growth factor 2 and cyclic AMP synergistically regulate bone sialoprotein gene expression', Bone, vol. 39, no. 1, pp. 42-52. https://doi.org/10.1016/j.bone.2005.12.011
Shimizu, Emi ; Nakayama, Youhei ; Nakajima, Yu ; Kato, Naoko ; Takai, Hideki ; Kim, Dong Soon ; Arai, Masato ; Saito, Ryoichiro ; Sodek, Jaro ; Ogata, Yorimasa. / Fibroblast growth factor 2 and cyclic AMP synergistically regulate bone sialoprotein gene expression. In: Bone. 2006 ; Vol. 39, No. 1. pp. 42-52.
@article{ccb37a4b2b244eb1b7e5a6fe3ba58017,
title = "Fibroblast growth factor 2 and cyclic AMP synergistically regulate bone sialoprotein gene expression",
abstract = "Bone sialoprotein (BSP) is a noncollagenous protein of the mineralized bone extracellular matrix. We here report that FGF2 and cAMP act synergistically to stimulate BSP gene expression. Treatment of ROS 17/2.8 cells with either 10 ng/ml FGF2 or 1 μM FSK for 6 h resulted in 5.4- and 8.2-fold increases, respectively, in the levels of BSP mRNA. However, in the presence of both FGF2 and forskolin (FGF/FSK), BSP mRNA levels were increased synergistically by 20.4-fold. Using a luciferase reporter construct, encompassing BSP promoter nucleotides -116 to +60, transcription was also increased synergistically by 15.0-fold with FGF/FSK, compared to stimulations of 2.6- and 5.3-fold, respectively, for FGF2 and FSK alone. Transcriptional stimulation by FGF/FSK abrogated in constructs included 2 bp mutations in the inverted CCAAT, CRE, FRE and Pit-1 elements. Whereas the FRE-protein complex was increased by FGF2 and FGF/FSK, the Pit-1-protein complex was decreased by FSK and FGF/FSK. Notably, transcriptional activity induced by FGF/FSK was blocked by protein kinase A, tyrosine kinase and MEK inhibitors. These studies indicate that the combinatorial effects of FGF and FSK act through PKA, tyrosine kinase and MAP-kinase-dependent pathways, which target the inverted CCAAT, CRE, FRE and Pit-1 elements in the BSP gene to synergistically increase BSP expression.",
keywords = "Basic fibroblast growth factor, Bone sialoprotein, cAMP, Gene expression",
author = "Emi Shimizu and Youhei Nakayama and Yu Nakajima and Naoko Kato and Hideki Takai and Kim, {Dong Soon} and Masato Arai and Ryoichiro Saito and Jaro Sodek and Yorimasa Ogata",
year = "2006",
month = "7",
doi = "10.1016/j.bone.2005.12.011",
language = "English (US)",
volume = "39",
pages = "42--52",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Fibroblast growth factor 2 and cyclic AMP synergistically regulate bone sialoprotein gene expression

AU - Shimizu, Emi

AU - Nakayama, Youhei

AU - Nakajima, Yu

AU - Kato, Naoko

AU - Takai, Hideki

AU - Kim, Dong Soon

AU - Arai, Masato

AU - Saito, Ryoichiro

AU - Sodek, Jaro

AU - Ogata, Yorimasa

PY - 2006/7

Y1 - 2006/7

N2 - Bone sialoprotein (BSP) is a noncollagenous protein of the mineralized bone extracellular matrix. We here report that FGF2 and cAMP act synergistically to stimulate BSP gene expression. Treatment of ROS 17/2.8 cells with either 10 ng/ml FGF2 or 1 μM FSK for 6 h resulted in 5.4- and 8.2-fold increases, respectively, in the levels of BSP mRNA. However, in the presence of both FGF2 and forskolin (FGF/FSK), BSP mRNA levels were increased synergistically by 20.4-fold. Using a luciferase reporter construct, encompassing BSP promoter nucleotides -116 to +60, transcription was also increased synergistically by 15.0-fold with FGF/FSK, compared to stimulations of 2.6- and 5.3-fold, respectively, for FGF2 and FSK alone. Transcriptional stimulation by FGF/FSK abrogated in constructs included 2 bp mutations in the inverted CCAAT, CRE, FRE and Pit-1 elements. Whereas the FRE-protein complex was increased by FGF2 and FGF/FSK, the Pit-1-protein complex was decreased by FSK and FGF/FSK. Notably, transcriptional activity induced by FGF/FSK was blocked by protein kinase A, tyrosine kinase and MEK inhibitors. These studies indicate that the combinatorial effects of FGF and FSK act through PKA, tyrosine kinase and MAP-kinase-dependent pathways, which target the inverted CCAAT, CRE, FRE and Pit-1 elements in the BSP gene to synergistically increase BSP expression.

AB - Bone sialoprotein (BSP) is a noncollagenous protein of the mineralized bone extracellular matrix. We here report that FGF2 and cAMP act synergistically to stimulate BSP gene expression. Treatment of ROS 17/2.8 cells with either 10 ng/ml FGF2 or 1 μM FSK for 6 h resulted in 5.4- and 8.2-fold increases, respectively, in the levels of BSP mRNA. However, in the presence of both FGF2 and forskolin (FGF/FSK), BSP mRNA levels were increased synergistically by 20.4-fold. Using a luciferase reporter construct, encompassing BSP promoter nucleotides -116 to +60, transcription was also increased synergistically by 15.0-fold with FGF/FSK, compared to stimulations of 2.6- and 5.3-fold, respectively, for FGF2 and FSK alone. Transcriptional stimulation by FGF/FSK abrogated in constructs included 2 bp mutations in the inverted CCAAT, CRE, FRE and Pit-1 elements. Whereas the FRE-protein complex was increased by FGF2 and FGF/FSK, the Pit-1-protein complex was decreased by FSK and FGF/FSK. Notably, transcriptional activity induced by FGF/FSK was blocked by protein kinase A, tyrosine kinase and MEK inhibitors. These studies indicate that the combinatorial effects of FGF and FSK act through PKA, tyrosine kinase and MAP-kinase-dependent pathways, which target the inverted CCAAT, CRE, FRE and Pit-1 elements in the BSP gene to synergistically increase BSP expression.

KW - Basic fibroblast growth factor

KW - Bone sialoprotein

KW - cAMP

KW - Gene expression

UR - http://www.scopus.com/inward/record.url?scp=33646870845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646870845&partnerID=8YFLogxK

U2 - 10.1016/j.bone.2005.12.011

DO - 10.1016/j.bone.2005.12.011

M3 - Article

VL - 39

SP - 42

EP - 52

JO - Bone

JF - Bone

SN - 8756-3282

IS - 1

ER -